Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer

Clinical trial NCT03732950 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03732950
Sponsor: Jonsson Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma

Start date: 2019-03-06
Primary completion: 2023-12-05
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.